BioCorRx (BICX) Free Cash Flow (2010 - 2026)
BioCorRx (BICX) posted Free Cash Flow of -$432971.0 for Q1 2026, up 48.93% sequentially from -$847722.0 in Q4 2025, and up 37.22% YoY from -$315539.1 in Q1 2025.
Powered by 
Analysis
BioCorRx (BICX) Free Cash Flow (2010 - 2026) Analysis & Trends
BioCorRx has reported Free Cash Flow for 17 years, with the latest figure at -$432971.0 in Q1 2026.
- Quarterly Free Cash Flow rose 37.22% year-over-year to -$432971.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 41.17% YoY) and the FY2025 annual result came in at -$2.3 million, down 109.65% from the prior year.
- Free Cash Flow improved to -$432971.0 in Q1 2026 per BICX's latest filing, from -$847722.0 in the prior quarter.
- Over five years, Free Cash Flow peaked at -$126499.0 in Q2 2025 and troughed at -$872672.0 in Q1 2022.
- A 5-year average of -$454268.9 and a median of -$397355.0 in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow surged 73.72% in 2022, then sank 242.97% in 2025.
- Over 5 years, Free Cash Flow stood at -$449576.0 in 2022, then declined by 18.74% to -$533836.0 in 2023, then soared by 53.7% to -$247170.0 in 2024, then tumbled by 242.97% to -$847722.0 in 2025, then surged by 48.93% to -$432971.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$432971.0, -$847722.0, and -$634447.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 1.10 Bn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | 417.00 Mn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | 62.30 Mn |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 320.25 Mn |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 215.67 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 119.13 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 69.29 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 31.23 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 119.55 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -432,971.00 |
| Dec 31, 2025 | -847,722.00 |
| Sep 30, 2025 | -634,447.00 |
| Jun 30, 2025 | -126,499.00 |
| Mar 31, 2025 | -689,623.00 |
| Dec 31, 2024 | -247,170.00 |
| Sep 30, 2024 | -357,543.00 |
| Jun 30, 2024 | -151,873.00 |
| Mar 31, 2024 | -339,668.00 |
| Dec 31, 2023 | -533,836.00 |
| Sep 30, 2023 | -350,548.00 |
| Jun 30, 2023 | -571,543.00 |
| Mar 31, 2023 | -397,355.00 |
| Dec 31, 2022 | -449,576.00 |
| Sep 30, 2022 | -367,820.00 |
| Jun 30, 2022 | -351,705.00 |
| Mar 31, 2022 | -872,672.00 |
| Dec 31, 2021 | -647,624.00 |
| Sep 30, 2021 | -621,716.00 |
| Jun 30, 2021 | -1.34 Mn |